Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity
Sai Zhang, Johnathan Cooper-Knock, Annika K. Weimer, Calum Harvey, Thomas H. Julian, Cheng Wang, Jingjing Li, Simone Furini, Elisa Frullanti, Francesca Fava, Alessandra Renieri, Cuiping Pan, Jina Song, Paul Billing-Ross, Peng Gao, Xiaotao Shen, Ilia Sarah Timpanaro, Kevin P. Kenna, VA Million Veteran Program, GEN-COVID Network, Mark M. Davis, Philip S. Tsao, Michael P. Snyder
doi: https://doi.org/10.1101/2021.06.15.21258703
Sai Zhang
1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
2Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA
Johnathan Cooper-Knock
3Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK
Annika K. Weimer
1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
2Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA
Calum Harvey
3Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK
Thomas H. Julian
3Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK
Cheng Wang
4Department of Neurology, School of Medicine, University of California, San Francisco, CA, USA
5Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA
6Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA
7Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA,USA
Jingjing Li
4Department of Neurology, School of Medicine, University of California, San Francisco, CA, USA
5Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA
6Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA
7Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA,USA
Simone Furini
8Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy
Elisa Frullanti
8Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy
9Medical Genetics, Department of Medical Biotechnologies, University of Siena, Siena, Italy
Francesca Fava
8Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy
9Medical Genetics, Department of Medical Biotechnologies, University of Siena, Siena, Italy
10Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy
Alessandra Renieri
8Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy
9Medical Genetics, Department of Medical Biotechnologies, University of Siena, Siena, Italy
10Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy
Cuiping Pan
11VA Palo Alto Epidemiology Research and Information Center for Genomics, VA Palo Alto Health Care System, Palo Alto, CA, USA
Jina Song
2Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA
11VA Palo Alto Epidemiology Research and Information Center for Genomics, VA Palo Alto Health Care System, Palo Alto, CA, USA
Paul Billing-Ross
2Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA
11VA Palo Alto Epidemiology Research and Information Center for Genomics, VA Palo Alto Health Care System, Palo Alto, CA, USA
Peng Gao
1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
2Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA
Xiaotao Shen
1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
2Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA
Ilia Sarah Timpanaro
12Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
Kevin P. Kenna
12Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
13A list of members and affiliations appears in the Supplementary file
Mark M. Davis
14Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
15Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
16Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA
Philip S. Tsao
11VA Palo Alto Epidemiology Research and Information Center for Genomics, VA Palo Alto Health Care System, Palo Alto, CA, USA
17Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
Michael P. Snyder
1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
2Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The GEN-COVID WES and clinical data are available by consultation (A.R.). The VA WGS and clinical data are available upon request from the corresponding authors (P.S.T. and M.P.S.); these data are not publicly available due to US Government and Department of Veteran's Affairs restrictions relating to participant privacy and consent. All other data used in this study are available from the original studies.
Posted June 21, 2021.
Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity
Sai Zhang, Johnathan Cooper-Knock, Annika K. Weimer, Calum Harvey, Thomas H. Julian, Cheng Wang, Jingjing Li, Simone Furini, Elisa Frullanti, Francesca Fava, Alessandra Renieri, Cuiping Pan, Jina Song, Paul Billing-Ross, Peng Gao, Xiaotao Shen, Ilia Sarah Timpanaro, Kevin P. Kenna, VA Million Veteran Program, GEN-COVID Network, Mark M. Davis, Philip S. Tsao, Michael P. Snyder
medRxiv 2021.06.15.21258703; doi: https://doi.org/10.1101/2021.06.15.21258703
Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity
Sai Zhang, Johnathan Cooper-Knock, Annika K. Weimer, Calum Harvey, Thomas H. Julian, Cheng Wang, Jingjing Li, Simone Furini, Elisa Frullanti, Francesca Fava, Alessandra Renieri, Cuiping Pan, Jina Song, Paul Billing-Ross, Peng Gao, Xiaotao Shen, Ilia Sarah Timpanaro, Kevin P. Kenna, VA Million Veteran Program, GEN-COVID Network, Mark M. Davis, Philip S. Tsao, Michael P. Snyder
medRxiv 2021.06.15.21258703; doi: https://doi.org/10.1101/2021.06.15.21258703
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2642)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12213)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4089)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2650)
- Health Policy (1004)
- Hematology (362)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3867)
- Nursing (209)
- Nutrition (577)
- Oncology (2025)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6518)
- Radiology and Imaging (1399)
- Respiratory Medicine (871)
- Rheumatology (406)
- Sports Medicine (342)
- Surgery (446)
- Toxicology (53)
- Transplantation (185)
- Urology (165)